A detailed history of Sei Investments CO transactions in Catalent, Inc. stock. As of the latest transaction made, Sei Investments CO holds 45,227 shares of CTLT stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,227
Previous 65,201 30.63%
Holding current value
$2.87 Million
Previous $3.67 Million 25.29%
% of portfolio
0.0%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.16 - $60.96 $1.12 Million - $1.22 Million
-19,974 Reduced 30.63%
45,227 $2.74 Million
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $1.49 Million - $1.59 Million
-27,814 Reduced 29.9%
65,201 $3.67 Million
Q1 2024

May 07, 2024

SELL
$42.56 - $59.82 $41,027 - $57,666
-964 Reduced 1.03%
93,015 $5.25 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $50,039 - $72,416
1,555 Added 1.68%
93,979 $4.22 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $390,109 - $443,065
8,826 Added 10.56%
92,424 $4.21 Million
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $15.7 Million - $33.2 Million
-492,972 Reduced 85.5%
83,598 $3.62 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $1.69 Million - $2.76 Million
37,227 Added 6.9%
576,570 $37.9 Million
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $8.91 Million - $17.4 Million
-215,388 Reduced 28.54%
539,343 $24.3 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $2.68 Million - $4.19 Million
37,079 Added 5.17%
754,731 $54.6 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $21.1 Million - $27.6 Million
242,184 Added 50.94%
717,652 $77 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $2.71 Million - $3.58 Million
28,732 Added 6.43%
475,468 $52.8 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $2.82 Million - $3.28 Million
23,615 Added 5.58%
446,736 $57.3 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $5.37 Million - $7 Million
49,195 Added 13.16%
423,121 $56.4 Million
Q2 2021

Aug 06, 2021

BUY
$100.34 - $115.69 $2.97 Million - $3.42 Million
29,584 Added 8.59%
373,926 $40.6 Million
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $2.01 Million - $2.48 Million
19,788 Added 6.1%
344,342 $36.3 Million
Q4 2020

Feb 08, 2021

SELL
$85.88 - $105.36 $2.15 Million - $2.64 Million
-25,063 Reduced 7.17%
324,554 $33.9 Million
Q3 2020

Dec 04, 2020

SELL
$72.74 - $92.5 $18,766 - $23,865
-258 Reduced 0.07%
349,617 $29.9 Million
Q3 2020

Nov 06, 2020

BUY
$72.74 - $92.5 $853,167 - $1.08 Million
11,729 Added 3.47%
349,875 $29.9 Million
Q2 2020

Aug 17, 2020

BUY
$48.02 - $79.04 $3.88 Million - $6.38 Million
80,765 Added 31.38%
338,146 $24.8 Million
Q2 2020

Aug 11, 2020

SELL
$48.02 - $79.04 $2.86 Million - $4.72 Million
-59,654 Reduced 18.82%
257,381 $14.6 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $2.24 Million - $3.81 Million
60,538 Added 23.6%
317,035 $16.5 Million
Q4 2019

Feb 06, 2020

BUY
$47.06 - $56.64 $1.57 Million - $1.89 Million
33,413 Added 14.98%
256,497 $14.5 Million
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $1.17 Million - $1.43 Million
24,603 Added 12.4%
223,084 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $1.26 Million - $1.74 Million
32,104 Added 19.3%
198,481 $10.8 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $718,099 - $1.06 Million
24,065 Added 16.91%
166,377 $6.76 Million
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $17,281 - $26,738
577 Added 0.41%
142,312 $6.45 Million
Q3 2018

Nov 08, 2018

BUY
$40.12 - $45.55 $472,934 - $536,943
11,788 Added 9.07%
141,735 $6.46 Million
Q2 2018

Aug 03, 2018

SELL
$38.72 - $42.52 $314,561 - $345,432
-8,124 Reduced 5.88%
129,947 $5.44 Million
Q1 2018

May 11, 2018

BUY
$39.4 - $47.39 $549,866 - $661,374
13,956 Added 11.24%
138,071 $5.67 Million
Q4 2017

Feb 08, 2018

BUY
$37.27 - $43.02 $1.11 Million - $1.29 Million
29,899 Added 31.73%
124,115 $5.1 Million
Q3 2017

Nov 06, 2017

BUY
$33.75 - $41.67 $3.18 Million - $3.93 Million
94,216
94,216 $3.76 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.